Illumina Announces Preliminary Revenue for First Quarter of Fiscal Year 2016
April 18 2016 - 4:05PM
Business Wire
Illumina, Inc. (NASDAQ: ILMN) today announced estimated first
quarter revenue of approximately $572 million, a 6% increase
compared to $539 million in the first quarter of 2015 and
7% growth on a constant currency basis. This estimate, which is
unaudited, is based on management's preliminary financial
analysis.
“Our first quarter results fell short of expectations largely
due to lower than expected sales of HiSeq 2500, 3000 and 4000
instruments. Despite this slow start in Q1, we anticipate that our
Americas and Asia Pacific regions will meet our expectations for
the full year, but that Europe will underperform. As a result, we
now project approximately 12% revenue growth for fiscal 2016,”
stated Jay Flatley, Chairman and CEO. “Given the disappointing
outlook in Europe, we have made management changes in the region
and plan to implement a program of actions to achieve our goal of
delivering the robust growth we believe the market can
support.”
Financial outlook and guidance
Updated GAAP and non-GAAP EPS guidance will be provided when
reporting first quarter results on May 3, 2016.
Pre-Announcement Conference Call Details
A brief conference call to discuss preliminary first quarter
results will be held today, April 18, 2016, at 1:30 pm Pacific Time
(4:30 pm Eastern Time). Interested parties may listen to the call
by dialing 888.687.3295 (passcode: 86049063), or if outside North
America by dialing +1.503.406.4070 (passcode: 86049063).
Individuals may access the live teleconference in the Investor
Relations section of Illumina’s web site under the “company” tab at
www.illumina.com.
A replay of the conference call will be available from 4:30 pm
Pacific Time (7:30 pm Eastern Time) through April 25, 2016 by
dialing 855.859.2056 (passcode: 86049063), or if outside North
America by dialing +1.404.537.3406 (passcode: 86049063).
First Fiscal Quarter Results Conference Call Details
The company also announced that results for first fiscal quarter
2016 will be issued following the close of market on Tuesday, May
3, 2016. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern
Time) Jay Flatley, Chairman and CEO, Francis deSouza, President,
and Marc Stapley, Executive Vice President, Chief Administrative
Officer, and Chief Financial Officer, will host a conference call
to discuss financial and operating results.
Interested parties may listen to the call by dialing
888.687.3295 (passcode: 85797542), or if outside North America by
dialing +1.503.406.4070 (passcode: 85797542). Individuals may
access the live teleconference in the Investor Relations section of
Illumina’s web site under the “company” tab at
www.illumina.com.
A replay of the conference call will be available from 5:00 pm
Pacific Time (8:00 pm Eastern Time) on May 3, 2016 through May 10,
2016 by dialing 855.859.2056 (passcode: 85797542), or if outside
North America by dialing +1.404.537.3406 (passcode: 85797542).
Use of forward-looking statements
This release contains projections, information about our
financial outlook, earnings guidance, and other forward-looking
statements that involve risks and uncertainties. These
forward-looking statements are based on our expectations as of the
date of this release and may differ materially from actual future
events or results. Among the important factors that could cause
actual results to differ materially from those in any
forward-looking statements are (i) our ability to further develop
and commercialize our instruments and consumables and to deploy new
products, services, and applications, and expand the markets, for
our technology platforms; (ii) our ability to manufacture robust
instrumentation and consumables; (iii) our ability to successfully
identify and integrate acquired technologies, products, or
businesses; (iv) our expectations and beliefs regarding future
conduct and growth of the business and the markets in which we
operate; (v) challenges inherent in developing, manufacturing, and
launching new products and services; and (vi) the application of
generally accepted accounting principles, which are highly complex
and involve many subjective assumptions, estimates, and judgments,
together with other factors detailed in our filings with the
Securities and Exchange Commission, including our most recent
filings on Forms 10-K and 10-Q, or in information disclosed in
public conference calls, the date and time of which are released
beforehand. We undertake no obligation, and do not intend, to
update these forward-looking statements, to review or confirm
analysts’ expectations, or to provide interim reports or updates on
the progress of the current quarter.
About Illumina
Illumina is improving human health by unlocking the power of the
genome. Our focus on innovation has established us as the global
leader in DNA sequencing and array-based technologies, serving
customers in the research, clinical and applied markets. Our
products are used for applications in the life sciences, oncology,
reproductive health, agriculture and other emerging
segments. To learn more, visit www.illumina.com and
follow @illumina.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160418006594/en/
Illumina, Inc.Investors:Rebecca
Chambers858.255.5243ir@illumina.comorMedia:Eric
Endicott858.882.6822pr@illumina.com
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Apr 2023 to Apr 2024